Toxocara canis: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "0 mg" to "0mg") |
(Text replacement - "OR" to "'''OR'''") |
||
| Line 12: | Line 12: | ||
==Management== | ==Management== | ||
*Diethylcarbamazine 6mg/kg/day divided TID x 7-10 days OR mebendazole 100-200mg BID x 5 days OR albendazole 400mg BID x 3-5 days | *Diethylcarbamazine 6mg/kg/day divided TID x 7-10 days '''OR''' mebendazole 100-200mg BID x 5 days '''OR''' albendazole 400mg BID x 3-5 days | ||
==Disposition== | ==Disposition== | ||
Latest revision as of 22:51, 30 May 2017
Background
Clinical Features
- Visceral toxocariasis (visceral larva migrans)
- Larvae travel through liver / lungs / CNS causing fever, cough, enlarged liver, pneumonia
- Ocular toxocariasis (ocular larva migrans)
- Larvae travel to the eye causing inflammation and scarring of retina, usually only one eye, irreversible vision loss
Differential Diagnosis
Workup
Management
- Diethylcarbamazine 6mg/kg/day divided TID x 7-10 days OR mebendazole 100-200mg BID x 5 days OR albendazole 400mg BID x 3-5 days